Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury

Journal of Experimental Medicine

Volumn 202, Issue 1, 2005, Pages 145-156

  Brambilla, Roberta ^a   Bracchi Ricard, Valerie ^a   Hu, Wen Hui ^a,c   Frydel, Beata ^a   Bramwell, Annmarie ^b   Karmally, Shaffiat ^a   Green, Edward J ^a,b   Bethea, John R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Department of Biology   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CONTUSION; CONVALESCENCE; EMBRYO; FEMALE; HISTOPATHOLOGY; INFLAMMATION; MACROGLIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPINAL CORD INJURY; TRANSGENIC MOUSE; WHITE MATTER;

ANIMALS; ASTROCYTES; BASE SEQUENCE; CHEMOKINES; CYTOKINES; DNA, COMPLEMENTARY; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NF-KAPPA B; PROTEOCHONDROITIN SULFATES; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES;

EID: 22344431751     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20041918     Document Type: Article

References (61)

1. Schwab, M.E. 2002. Repairing the injured spinal cord. Science. 295: 1029-1031.
2. Popovich, P.G., and T.B. Jones. 2003. Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol. Sci. 24:13-17.
3. Ridet, J.L., S.K. Malhotra, A. Privat, and F.H. Gage. 1997. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 20:570-577.
4. Liberto, C.M., P.J. Albrecht, L.M. Herx, V.W. Yong, and S.W. Levison. 2004. Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 89:1092-1100.
5. Faulkner, J.R., J.E. Herrmann, M.J. Woo, K.E. Tansey, N.B. Doan, and M.V. Sofroniew. 2004. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24:2143-2155.
6. Menet, V., M. Prieto, A. Privat, and M. Gimenez y Ribotta. 2003 Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes. Proc. Natl. Acad. Sci. USA. 100:8999-9004.
7. O'Neill, L.A., and C. Kaltschmidt. 1997. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20: 252-258.
8. Bethea, J.R., M. Castro, R.W. Keane, T.T. Lee, W.D. Dietrich, and R.P. Yezierski. 1998. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J. Neurosci. 18:3251-3260.
9. Schneider, A., A. Martin-Villalba, F. Weih, J. Vogel, T. Wirth, and M. Schwaninger. 1999. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5:554-559.
10. Nomoto, Y., M. Yamamoto, T. Fukushima, H. Kimura, K. Ohshima, and M. Tomonaga. 2001. Expression of nuclear factor kappaB and tumor necrosis factor alpha in the mouse brain after experimental thermal ablation injury. Neurosurgery. 48:158-166.
11. Beni, S.M., R. Kohen, R.J. Reiter, D.X. Tan, and E. Shohami. 2004. Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappaB and AP-1. FASEB J. 18:149-151.
12. Bethea, J.R., H. Nagashima, M.C. Acosta, C. Briceno, F. Gomez, A.E. Marcillo, K. Loor, J. Green, and W.D. Dietrich. 1999. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma. 16:851-863.
13. Siren, A.L., R. McCarron, L. Wang, P. Garcia-Pinto, C. Ruetzler, D. Martin, and J.M. Hallenbeck. 2001. Proinflammatory cytokine expression contributes to brain injury provoked by chronic monocyte activation. Mol. Med. 7:219-229.
14. de Freitas, M.S., T.C. Spohr, A.B. Benedito, M.S. Caetano, B. Margulis, U.G. Lopes, and V. Moura-Neto. 2002. Neurite outgrowth is impaired on HSP70-positive astrocytes through a mechanism that requires NF-kappaB activation. Brain Res. 958:359-370.
15. Acarin, L., B. Gonzalez, and B. Castellano. 2001. Triflusal posttreatment inhibits glial nuclear factor-kappaB, downregulates the glial response, and is neuroprotective in an excitotoxic injury model in postnatal brain. Stroke. 32:2394-2402.
16. Zaheer, A., M.A. Yorek, and R. Lim. 2001. Effects of glia maturation factor overexpression in primary astrocytes on MAP kinase activation, transcription factor activation, and neurotrophin secretion. Neurochem. Res. 26:1293-1299.
17. Mattson, M.P., B. Cheng, S.A. Baldwin, V.L. Smith-Swintosky, J. Keller, J.W. Geddes, S.W. Scheff, and S. Christakos. 1995. Brain injury and tumor necrosis factors induce calbindin D-28k in astrocytes: evidence for a cytoprotective response. J. Neurosci. Res. 42:357-370.
18. Beg, A.A., W.C. Sha, R.T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 376:167-170.
19. Sha, W.C., H.C. Liou, E.I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell. 80:321-330.
20. Jessen, K.R., L. Morgan, H.J. Stewart, and R. Mirsky. 1990. Three markers of adult non-myelin-forming Schwann cells, 217c(Ran-1), A5E3 and GFAP: development and regulation by neuron-Schwann cell interactions. Development. 109:91-103.
21. Kucharczak, J., M.J. Simmons, Y. Fan, and C. Gelinas. 2003. To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene. 22:8961-8982.
22. Viatour, P., M.P. Merville, V. Bours, and A. Chariot. 2005. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 30:43-52.
23. Basso, D.M., and L.F. Fisher. 2003. The Basso mouse scale for locomotion is a more sensitive indicator of recovery than the BBB scale in mice with spinal cord injury. J. Rehab. Research Dev. 40:26.
24. Lagord, C., M. Berry, and A. Logan. 2002. Expression of TGFbeta2 but not TGFbeta1 correlates with the deposition of scar tissue in the lesioned spinal cord. Mol. Cell. Neurosci. 20:69-92.
25. Iozzo, R.V. 1999. The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J. Biol. Chem. 274:18843-18846.
26. McTigue, D.M., M. Tani, K. Krivacic, A. Chernosky, G.S. Kelner, D. Maciejewski, R. Maki, R.M. Ransohoff, and B.T. Stokes. 1998. Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury. J. Neurosci. Res. 53:368-376.
27. Sroga, J.M., T.B. Jones, K.A. Kigerl, V.M. McGaughy, and P.G. Popovich. 2003. Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J. Comp. Neurol. 462:223-240.
28. Wang, C.X., B. Nuttin, H. Heremans, R. Dom, and J. Gybels. 1996. Production of tumor necrosis factor in spinal cord following traumatic injury in rats. J. Neuroimmunol. 69:151-156.
29. Beg, A.A., and D. Baltimore. 1996. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science. 274:782-784.
30. Grumont, R.J., I.J. Rourke, L.A. O'Reilly, A. Strasser, K. Miyake, W. Sha, and S. Gerondakis. 1998. B lymphocytes differentially use the Rel and nuclear factor κB1 (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 187:663-674.
31. McKeon, R.J., M.J. Jurynec, and C.R. Buck. 1999. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J. Neurosci. 19:10778-10788.
32. Asher, R.A., D.A. Morgenstern, P.S. Fidler, K.H. Adcock, A. Oohira, J.E. Braistead, J.M. Levine, R.U. Margolis, J.H. Rogers, and J.W. Fawcett. 2000. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J. Neurosci. 20:2427-2438.
33. Bradbury, E.J., L.D. Moon, R.J. Popat, V.R. King, G.S. Bennett, P.N. Patel, J.W. Fawcett, and S.B. McMahon. 2002. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature. 416:636-640.
34. Grimpe, B., and J. Silver. 2004. A novel DNA enzyme reduces glycosaminoglycan chains in the glial scar and allows microtransplanted dorsal root ganglia axons to regenerate beyond lesions in the spinal cord. J. Neurosci. 24:1393-1397.
35. Westergren-Thorsson, G., A. Schmidtchen, B. Sarnstrand, L.A. Fransson, and A. Malmstrom. 1992. Transforming growth factor-beta induces selective increase of proteoglycan production and changes in the copolymeric structure of dermatan sulphate in human skin fibroblasts. Eur. J. Biochem. 205:277-286.
36. Romaris, M., A. Bassols, and G. David. 1995. Effect of transforming growth factor-beta 1 and basic fibroblast growth factor on the expression of cell surface proteoglycans in human lung fibroblasts. Enhanced glycanation and fibronectin-binding of CD44 proteoglycan, and down-regulation of glypican. Biochem. J. 310:73-81.
37. Rameshwar, P., R. Narayanan, J. Qian, T.N. Denny, C. Colon, and P. Gascon. 2000. NF-kappa B as a central mediator in the induction of TGF-beta in monocytes from patients with idiopathic myelofibrosis: an inflammatory response beyond the realm of homeostasis. J. Immunol. 165:2271-2277.
38. Strauch, E.D., J. Yamaguchi, B.L. Bass, and J.Y. Wang. 2003. Bile salts regulate intestinal epithelial cell migration by nuclear factor-kappa B-induced expression of transforming growth factor-beta. J. Am. Coll. Surg. 197:974-984.
39. Davies, J.E., X. Tang, J.W. Denning, S.J. Archibald, and S.J. Davies. 2004. Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries. Eur. J. Neurosci. 19:1226-1242.
40. Stander, M., U. Naumann, W. Wick, and M. Weller. 1999. Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res. 296:221-227.
41. Santra, M., C.C. Reed, and R.V. Iozzo. 2002. Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope. J. Biol. Chem. 277:35671-35681.
42. Gonzalez, R., J. Glaser, M.T. Liu, T.E. Lane, and H.S. Keirstead. 2003. Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury. Exp. Neurol. 184:456-463.
43. Glaser, J., R. Gonzalez, V.M. Perreau, C.W. Cotman, and H.S. Keirstead. 2004. Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury. J. Neurosci. Res. 77:701-708.
44. Mancardi, S., E. Vecile, N. Dusetti, E. Calvo, G. Stanta, O.R. Burrone, and A. Dobrina. 2003. Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells. Immunology. 108:523-530.
45. Piali, L., C. Weber, G. LaRosa, C.R. Mackay, T.A. Springer, I. Clark-Lewis, and B. Moser. 1998. The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig. Eur. J. Immunol. 28:961-972.
46. Feng, L., C. Matsumoto, A. Schwartz, A.M. Schmidt, D.M. Stern, and J. Pile-Spellman. 2005. Chronic vascular inflammation in patients with type 2 diabetes: endothelial biopsy and RT-PCR analysis. Diabetes Care. 28:379-384.
47. Loddick, S.A., A.V. Turnbull, and N.J. Rothwell. 1998. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 18:176-179.
48. Carlson, N.G., W.A. Wieggel, J. Chen, A. Bacchi, S.W. Rogers, and L.C. Gahring. 1999. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J. Immunol. 163:3963-3968.
49. Thorns, V., G.F. Walter, and F. Licastro. 2002. Effects of IL6 and IL1beta on aFGF expression and excitotoxicity in NT2N cells. J. Neuroimmunol. 127:22-29.
50. Cafferty, W.B., N.J. Gardiner, P. Das, J. Qiu, S.B. McMahon, and S.W. Thompson. 2004. Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice. J. Neurosci. 24:4432-4443.
51. Barkett, M., and T.D. Gilmore. 1999. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene. 18:6910-6924.
52. Rajkumar, S.V., P.G. Richardson, T. Hideshima, and K.C. Anderson. 2005. Proteasome inhibition as a novel therapeutic target in human cancer. J. Clin. Oncol. 23:630-639.
53. Elliott, P.J., T.M. Zollner, and W.H. Boehncke. 2003. Proteasome inhibition: a new anti-inflammatory strategy. J. Mol. Med. 81:235-245.
54. Brenner, M., W.C. Kisseberth, Y. Su, F. Besnard, and A. Messing. 1994. GFAP promoter directs astrocyte-specific expression in transgenic mice. J. Neurosci. 14:1030-1037.
55. Brockman, J.A., D.C. Scherer, T.A. McKinsey, S.M. Hall, X. Qi, W.Y. Lee, and D.W. Ballard. 1995. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol. Cell. Biol. 15:2809-2818.
56. Jakeman, L.B., Z. Guan, P. Wei, R. Ponnappan, R. Dzwonczyk, P.G. Popovich, and B.T. Stokes. 2000. Traumatic spinal cord injury produced by controlled contusion in mouse. J. Neurotrauma. 17:299-319.
57. Basso, D.M., M.S. Beattie, and J.C. Bresnahan. 1995. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma. 12:1-21.
58. Gundersen, H.J., P. Bagger, T.F. Bendtsen, S.M. Evans, L. Korbo, N. Marcussen, A. Moller, K. Nielsen, J.R. Nyengaard, B. Pakkenberg, et al. 1988. The new stereological tools: dissector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS. 96:857-881.
59. Noble, L.J., and J.R. Wrathall. 1985. Spinal cord contusion in the rat: morphometric analyses of alterations in the spinal cord. Exp. Neurol. 88:135-149.
60. Bolego, C., S. Ceruti, R. Brambilla, L. Puglisi, F. Cattabeni, G. Burnstock, and M.P. Abbracchio. 1997. Characterization of the signalling pathways involved in ATP and basic fibroblast growth factor-induced astrogliosis. Br. J. Pharmacol. 121:1692-1699.
61. Dignam, J.D., R.M. Lebovitz, and R.G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.